584 filings
Page 7 of 30
8-K
nr3rpe43j0kkifht0
3 Dec 18
Departure of Directors or Certain Officers
12:00am
S-8
ecb629un3jhtxfa
30 Nov 18
Registration of securities for employees
4:41pm
8-K
m0e08a
30 Nov 18
Other Events
4:14pm
8-K
0hicc omk
27 Nov 18
Altimmune Appoints Vipin K. Garg, Ph.D. as its New President and Chief Executive Officer
4:34pm
8-K
pyw4sgpast9
13 Nov 18
Altimmune Announces Third Quarter 2018
4:57pm
8-K
b86 gow7u0v1i
22 Oct 18
Departure of Directors or Certain Officers
4:30pm
424B5
tl97v cat3
9 Oct 18
Prospectus supplement for primary offering
5:20pm
424B5
1aipu
9 Oct 18
Prospectus supplement for primary offering
9:27am
8-K
u2hg 3gdb
9 Oct 18
Altimmune Announces $25 million Registered Direct Offering
9:14am
CT ORDER
8erl jcvyaa497ffyhv
4 Oct 18
Confidential treatment order
10:54am
8-K
opk10
1 Oct 18
Other Events
5:23pm
424B4
8xnczzc1hjxhb0s
1 Oct 18
Prospectus supplement with pricing info
5:16pm
POS EX
rh4tp bbdb7qmg0p2
28 Sep 18
Additional exhibits for listing
7:50am
EFFECT
0qlgrxvylef
28 Sep 18
Notice of effectiveness
12:15am
CORRESP
12c7me55tld7b27x23
27 Sep 18
Correspondence with SEC
12:00am
CORRESP
95zlz5m 81r
27 Sep 18
Correspondence with SEC
12:00am
8-K
7tscspppqn2ht
25 Sep 18
Altimmune Announces $4.9 million Registered Direct Offering of Common Stock
6:06am
424B5
qvk6fpx9 7mz
24 Sep 18
Prospectus supplement for primary offering
1:48pm